Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04612530
What this trial is testing

PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic Cancer
Amsterdam UMC, location VUmc 18
Testing effectiveness (Phase 2)Study completedNCT03321630
What this trial is testing

A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies

Who this might be right for
GastroEsophageal CancerGastric Cancer
NYU Langone Health 24
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Testing effectiveness (Phase 2)Ended earlyNCT03790111
What this trial is testing

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
TerSera Therapeutics LLC 53
Testing effectiveness (Phase 2)Study completedNCT02414009
What this trial is testing

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 82
Large-scale testing (Phase 3)Study completedNCT03766295
What this trial is testing

Masitinib Plus Gemcitabine in Pancreatic Cancer

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer
AB Science 377
Testing effectiveness (Phase 2)Looking for participantsNCT06341595
What this trial is testing

Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

Who this might be right for
Gastric CancerGastric Cancer Metastatic to Regional Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University 40
Large-scale testing (Phase 3)Study completedNCT02184195
What this trial is testing

Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Who this might be right for
Germline BRCA1/2 Mutations andMetastatic Adenocarcinoma of the Pancreas
AstraZeneca 154
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Looking for participantsNCT06208371
What this trial is testing

Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM

Who this might be right for
Colorectal Neoplasms Malignant
Sun Yat-sen University 117
Testing effectiveness (Phase 2)WithdrawnNCT05251038
What this trial is testing

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic Cancer+1 more
Devalingam Mahalingam
Early research (Phase 1)Study completedNCT01487785
What this trial is testing

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476
What this trial is testing

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 32
Early research (Phase 1)Not Yet RecruitingNCT07707674
What this trial is testing

Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Evopoint Biosciences Inc. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Testing effectiveness (Phase 2)Study completedNCT04534218
What this trial is testing

Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer

Who this might be right for
Colo-rectal CancerMetastatic Cancer
Centre Hospitalier Universitaire de Besancon 49
Not applicableStudy completedNCT04880772
What this trial is testing

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

Who this might be right for
Cancer of ColonCancer of RectumLiver Metastases
East Lancashire Hospitals NHS Trust 42
Testing effectiveness (Phase 2)Study completedNCT01575730
What this trial is testing

Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

Who this might be right for
Peritoneal Carcinomatosis
University Hospital, Ghent 45
Testing effectiveness (Phase 2)UnknownNCT05551247
What this trial is testing

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 30
Large-scale testing (Phase 3)Study completedNCT00004252
What this trial is testing

Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Pfizer
Next Page